International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7945451
Original Article
A Study to Analyse Association of H.Pylori Infections in Patients of Obstructive Sleep Apnea (OSA) Presenting with Symptoms of Gerd
 ,
 ,
 ,
 ,
Published
May 17, 2023
Abstract
Introduction: Several studies identified a link between gastroesophageal reflux disease (GERD) andobstructive sleep apnea (OSA). GERD is a condition in which acid reflux from the stomach to theoesophaguscauses troublesome symptoms. On the other hand, OSA is defined as a sleep-related breathing disorder inwhich airflow significantly decreases or ceases due to upper airway obstruction, leading to arousal fromsleep. OSA was found to be associated with GERD. In this study ,we aim to analyse the association of H.pylori infection in patients of obstructive sleep apnea presenting with symptoms of GERD . Methods:40 patients with symptoms of obstructive sleep apnea and gastroesophageal reflux diseases were enrolled . They underwent polysomnography and esophageogastroduodenoscopy .biopsy samples were taken and sent for histopathological examination with giemsa stain . Results: Out of 40 patients, 34 patients have giemsa positive h.pylori gastritis on biopsy (p=0.001)prevalence of h.pylori infection increases with severity of obstructive sleep apnea. Inmoderate osa (17.65%) , severe osa ( 82.35%)( p=0.004) Conclusion: This study concludes that there is significant association of h.pylori infection with OSA presenting with symptoms of GERD. Also, prevalence of h. pylori infection increases with severity of OSA.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
1955 Views
263 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved